Skip to main content
. 2015 Aug 17;51(2):66–80. doi: 10.4068/cmj.2015.51.2.66

TABLE 5. Clinical considerations in the use of aripiprazole augmentation for major depressive disorder (MDD).

graphic file with name cmj-51-66-i005.jpg

SSRI: selective serotonin reuptake inhibitor, SNRI: serotonin-norepinephrine reuptake inhibitor.